| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $2,960,110 | 3 | 60 |
Sells | $134,661 | 2 | 40 |
| BOURLA ALBERT | Chairman & CEO | 1 | $1M | 0 | $0 | $1M |
| BLAYLOCK RONALD E | director | 1 | $998,821 | 0 | $0 | $998,821 |
| Buckley Mortimer J | director | 1 | $960,369 | 0 | $0 | $960,369 |
| DAMICO JENNIFER B. | SVP & Controller | 0 | $0 | 2 | $134,661 | $-134,661 |
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, …
Over the last 12 months, insiders at Pfizer Inc. have bought $2.96M and sold $134,661 worth of Pfizer Inc. stock.
On average, over the past 5 years, insiders at Pfizer Inc. have bought $910,957 and sold $9.13M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BOURLA ALBERT (Chairman & CEO) — $1M. BLAYLOCK RONALD E (director) — $998,821. Buckley Mortimer J (director) — $960,369.
The last purchase of 38,000 shares for transaction amount of $1M was made by BOURLA ALBERT (Chairman & CEO) on 2026‑08‑12.
| 2026-08-12 | BOURLA ALBERT | Chairman & CEO | 38,000 0.0007% | $26.34 | $1M | +7.53% | ||
| 2026-08-05 | Sale | DAMICO JENNIFER B. | SVP & Controller | 3,278 <0.0001% | $25.40 | $83,261 | +9.18% | |
| 2026-08-05 | BLAYLOCK RONALD E | director | 39,231 0.0007% | $25.46 | $998,821 | +9.18% | ||
| 2026-08-05 | Buckley Mortimer J | director | 37,632 0.0007% | $25.52 | $960,369 | +9.18% | ||
| 2026-06-09 | Sale | DAMICO JENNIFER B. | SVP & Controller | 2,000 <0.0001% | $25.70 | $51,400 | +8.94% | |
| 2025-03-04 | Sale | DAMICO JENNIFER B. | SVP & Controller | 2,500 <0.0001% | $25.93 | $64,825 | -0.17% | |
| 2025-02-13 | BLAYLOCK RONALD E | director | 19,457 0.0003% | $25.65 | $499,072 | +0.17% | ||
| 2024-10-30 | Gottlieb Scott | director | 1,000 <0.0001% | $28.24 | $28,240 | -7.67% | ||
| 2024-08-13 | Sale | DAMICO JENNIFER B. | SVP & Controller | 5,154 <0.0001% | $28.66 | $147,714 | -7.68% | |
| 2023-12-15 | Gottlieb Scott | director | 3,000 <0.0001% | $26.47 | $79,401 | +7.75% | ||
| 2023-05-08 | Gottlieb Scott | director | 1,000 <0.0001% | $38.58 | $38,580 | -19.06% | ||
| 2023-05-05 | Gottlieb Scott | director | 1,000 <0.0001% | $38.42 | $38,425 | -18.41% | ||
| 2023-03-15 | Sale | DAMICO JENNIFER B. | SVP & Controller | 9,912 0.0002% | $40.02 | $396,678 | -13.65% | |
| 2022-06-07 | Sale | DAMICO JENNIFER B. | SVP & Controller | 4,218 <0.0001% | $53.96 | $227,603 | -14.85% | |
| 2022-05-13 | Sale | SAHNI PAYAL | Executive Vice President | 1,408 <0.0001% | $49.84 | $70,175 | -5.32% | |
| 2022-05-13 | Sale | DAMICO JENNIFER B. | SVP & Controller | 4,000 <0.0001% | $50.50 | $202,000 | -5.32% | |
| 2022-05-12 | Sale | LANKLER DOUGLAS M | Executive Vice President | 38,273 0.0007% | $49.41 | $1.89M | -6.06% | |
| 2022-05-12 | Sale | Carapezzi William R JR | Executive Vice President | 32,908 0.0006% | $50.00 | $1.65M | -6.06% | |
| 2022-05-11 | Sale | Dolsten Mikael | President R&D | 32,015 0.0006% | $49.31 | $1.58M | -3.29% | |
| 2021-12-03 | Sale | JOHNSON RADY A | Executive Vice President | 38,000 0.0007% | $53.42 | $2.03M | -5.93% |
| BOURLA ALBERT | Chairman & CEO | 429173 0.0075% | $12.88M | 1 | 2 | |
| BLAYLOCK RONALD E | director | 66938 0.0012% | $2.01M | 3 | 0 | +1.17% |
| Buckley Mortimer J | director | 37632 0.0007% | $1.13M | 1 | 0 | |
| SIMMONS DAVID S | Business Unit President | 134404 0.0024% | $4.03M | 1 | 0 | +21.21% |
| SUSMAN SALLY | Executive Vice President | 89575 0.0016% | $2.69M | 1 | 11 | <0.0001% |
| BURT ROBERT N | director | 12200 0.0002% | $366,000.00 | 1 | 0 | +18.61% |
| NORA JOHNSON SUZANNE M | director | 10000 0.0002% | $300,000.00 | 1 | 0 | <0.0001% |
| Gottlieb Scott | director | 10000 0.0002% | $300,000.00 | 6 | 0 | <0.0001% |
| KILTS JAMES M | director | 0 0% | $0 | 1 | 5 | <0.0001% |
| CORNWELL W DON | director | 0 0% | $0 | 3 | 5 | <0.0001% |
| SIMMONS RUTH J | director | 1200 0% | $36,000.00 | 1 | 0 | <0.0001% |
| SMITH JAMES C | director | 1542 0% | $46,260.00 | 1 | 1 | +4.65% |
$1,927,310,793 | 31 | 28.02% | $1,325.87B | |
$364,368,632 | 29 | 9.65% | $36.8B | |
$6,224,380 | 25 | 3.58% | $640.75B | |
$23,541,811 | 22 | 6.43% | $126.14B | |
$28,542,809 | 19 | 26.39% | $505.4B |
| Increased Positions | 1,393 | +41.87% | 200M | +5.26% |
| Decreased Positions | 1,538 | -46.23% | 258M | -6.8% |
| New Positions | 296 | New | 44M | New |
| Sold Out Positions | 205 | Sold Out | 45M | Sold Out |
| Total Postitions | 3,182 | -4.36% | 4B | -1.54% |
| Vanguard Group Inc | $13.6M | 9.5% | 540.14M | +5M | +0.99% | 2025-09-30 |
| Blackrock, Inc. | $12.62M | 8.82% | 501.27M | +5M | +1.04% | 2025-09-30 |
| State Street Corp | $7.59M | 5.3% | 301.6M | +5M | +1.58% | 2025-09-30 |
| Geode Capital Management, Llc | $3.28M | 2.29% | 130.41M | +2M | +1.93% | 2025-09-30 |
| Norges Bank | $2.36M | 1.65% | 93.65M | +6M | +6.68% | 2025-06-30 |
| Morgan Stanley | $1.89M | 1.32% | 74.86M | +5M | +6.64% | 2025-09-30 |
| Northern Trust Corp | $1.62M | 1.13% | 64.46M | +1M | +1.85% | 2025-09-30 |
| Wellington Management Group Llp | $1.61M | 1.13% | 64.12M | -16M | -20.28% | 2025-09-30 |
| Massachusetts Financial Services Co /Ma/ | $1.45M | 1.01% | 57.59M | -18M | -23.95% | 2025-09-30 |
| State Farm Mutual Automobile Insurance Co | $1.37M | 0.96% | 54.51M | 0 | 0% | 2025-09-30 |